CytoDyn Inc. Gains (Losses) on Restructuring of Debt
CytoDyn Inc. (CYDY) reported Gains (Losses) on Restructuring of Debt of $0 for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnRestructuringOfDebt · last filed 2026-08-31
- CytoDyn Inc. gains (losses) on restructuring of debt for the quarter ending 2025-05-31 was $0.00.
- CytoDyn Inc. gains (losses) on restructuring of debt for the quarter ending 2025-02-28 was $327.00K.
- CytoDyn Inc. gains (losses) on restructuring of debt for the quarter ending 2024-11-30 was $80.00K.
- CytoDyn Inc. gains (losses) on restructuring of debt for fiscal 2026 was $0.00, a 100.00% decline from fiscal 2025.
- CytoDyn Inc. gains (losses) on restructuring of debt for fiscal 2025 was $407.00K.
| Period end | Gains (Losses) on Restructuring of Debt 3 month | Gains (Losses) on Restructuring of Debt 6 month | Gains (Losses) on Restructuring of Debt 9 month | Gains (Losses) on Restructuring of Debt 12 month |
|---|---|---|---|---|
| 2026-05-31 | $0.00 10-K · filed 2026-08-31 | |||
| 2025-05-31 | $0.00 derived: 10-K 12 month − S-1 9 month · filed 2026-08-31 | $327.00K derived: sum of 2 quarters · filed 2026-08-31 | $407.00K derived: sum of 3 quarters · filed 2026-08-31 | $407.00K 10-K · filed 2026-08-31 |
| 2025-02-28 | $327.00K 10-Q · filed 2026-04-08 | $407.00K derived: sum of 2 quarters · filed 2026-04-08 | $407.00K S-1 · filed 2026-04-22 | |
| 2024-11-30 | $80.00K 10-Q · filed 2026-01-09 | $80.00K 10-Q · filed 2026-01-09 |